Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare

New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare Roger Tomlins (pictured right), who joins Wilmington from Bristol-Myers Squibb, has worked in healthcare for over 16 years, in both the pharmaceutical industry and the NHS.

BMS’ Opdivo/Yervoy combo scores in front-line lung cancer

BMS’ Opdivo/Yervoy combo scores in front-line lung cancer Makes case for duo therapy in NSCLC patients. Bristol-Myers Squibb has announced positive results from its pivotal phase 3 CheckMate-9LA, making a case for its cancer drug combo in

Roche eyes filings for Tecentriq/Avastin combo in liver cancer

Roche eyes filings for Tecentriq/Avastin combo in liver cancer Bristol-Myers Squibb.

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial market, latterly eclipsed by the stellar growth of checkpoint inhibitors from the likes of Merck &Co/MSD and Bristol-Myers Squibb.

BMS plugs on with Opdivo plus Yervoy in first-line NSCLC

BMS plugs on with Opdivo plus Yervoy in first-line NSCLC Could be an alternative treatment option to chemotherapy. Bristol-Myers Squibb isn’t giving up on its aspiration for Opdivo in first-line non-small cell lung cancer (NSCLC), a category

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...

Infographics